DALLAS (News release) -- Kimberly‑Clark Corporation announced the organizational structure and key leadership that will become effective upon completion of its pending acquisition of Kenvue Inc. The organizational structure, roles, and responsibilities reflect the fast-and-lean, balanced matrix approach that has built strong operating momentum at Kimberly-Clark since implementing its Powering Care strategy two years ago.

"We are excited to name the leadership team that will guide us forward to create a new kind of health and wellness company poised to raise the standard of care for billions of consumers across every stage of life," said Mike Hsu, Chairman and Chief Executive Officer of Kimberly‑Clark. "Our team was selected after a thorough and thoughtful process and reflects leaders with the right blend of experience, capabilities, and technical expertise to unlock the full potential of our combined portfolio, iconic brands, and talented people. Our structure is designed to align our teams around a shared mindset of ownership, agility, and speed. Markets will own the business end-to-end with the functions bringing our best capabilities to the markets - at speed - to help them win. Together, we will bring our global might to the local fight and drive durable, repeatable growth that will capitalize on the generational opportunity we have ahead."

Organizational Structure and Key Leadership

After close, the combined company will operate with four business segments, each driving a focus on winning in its local markets:

North America, a business generating approximately $18.0 billion¹ in sales annually;
Asia Pacific Focus Markets, which will include Greater China, Australia / New Zealand, South Korea, and Indonesia, generating approximately $4.3 billion¹ in annual sales;
Europe, Middle East, and Africa (EMEA), with approximately $5.0 billion¹ in annual sales; and
Enterprise Markets, which will include Latin America (including Brazil), India, Southeast Asia markets, and Japan, generating approximately $4.3 billion¹ in annual sales.

As previously announced, Mr. Hsu will continue to serve as Chairman and CEO of the combined company. The following future leaders will report directly to Mr. Hsu:

Russ Torres, Group President and Chief Operations Officer
Nelson Urdaneta, Chief Financial Officer
Stacey Valy Panayiotou, Chief Human Resources Officer
Jeff Melucci, Chief Strategy, Business Development and Administrative Officer
John Carmichael, President North America
Katy Chen, President Asia Pacific Focus Markets
Carlton Lawson, President EMEA

"Today is an important milestone that demonstrates the tremendous progress we have been making to ensure we hit the ground running on Day 1," said Russ Torres, President and Chief Operating Officer of Kimberly-Clark, and Head of the Integration Management Office. "The work of more than 30 workstreams across the integration team has identified our biggest growth and efficiency opportunities as well as the sequencing of priorities following transaction close. We are organizing to bring the best capabilities to the markets at speed and focus on the places where we can unlock significant value creation."

The following leaders will report to Mr. Torres:

Anindya Dasgupta, President Enterprise Markets
Carlos De Jesus, Chief Growth Officer
Craig Slavtcheff, Chief Research & Development Officer
Tamera Fenske, Chief Supply Chain Officer
Michael Wondrasch, Chief Consumer Growth Technology Officer
Francesco Tinto, Chief Information and Global Business Services Officer

The leadership team for the combined company will also include:

Leonardo Curado, General Manager LATAM, who will report to Mr. Dasgupta
Jonathan Halvorson, Chief Marketing Officer, who will report to Mr. De Jesus
Grant McGee, General Counsel, Russell Dyer, Chief Corporate Affairs Officer and Alan Ross, Head of Strategy, who will report to Mr. Melucci

Full biographies for the post-closing key leadership members are available on the transaction website: leadinghealthandwellness.com.

Mr. Hsu continued, "K-C and Kenvue have a talented and dedicated group of leaders at both companies. I am grateful to those leaders who will be transitioning from their roles at closing for their contributions and for the important role they continue to play in driving business momentum as we bring our companies together."

The transaction remains on track to close in the second half of 2026, subject to the receipt of regulatory approvals and satisfaction of other remaining customary closing conditions.